| ACNS0332-Tumor-Annotations | Medulloblastoma | Head | 85 | ACNS0332 | Tumor segmentations, Seed points | 03/21/2023 |
| AHOD0831-Tumor-Annotations | Hodgkin Lymphoma | Various | 165 | AHOD0831 | Tumor segmentations, Seed points | 02/10/2023 |
| AREN0532-Tumor-Annotations | Wilms Tumor | Kidney | 543 | AREN0532 | Tumor segmentations, Seed points | 02/09/2023 |
| AREN0533-Tumor-Annotations | Wilms Tumor | Kidney | 294 | AREN0533 | Tumor segmentations, Seed points | 01/31/2023 |
| AREN0534-Tumor-Annotations | Wilms Tumor | Kidney | 239 | AREN0534 | Tumor segmentations, Seed points | 02/09/2023 |
| BraTS-TCGA-GBM | Glioblastoma | Brain | 135 | TCGA-GBM | Tumor segmentations, radiomic image features | 07/17/2017 |
| BraTS-TCGA-LGG | Low Grade Glioma | Brain | 108 | TCGA-LGG | Tumor segmentations, radiomic image features | 07/17/2017 |
| CALGB50303-Tumor-Annotations | Lymphoma | Various | 155 | CALGB50303 | Tumor segmentations, Seed points | 11/22/2023 |
| CPTAC-CCRCC-Tumor-Annotations | Clear Cell Carcinoma | Kidney | 60 | CPTAC-CCRCC | Tumor segmentations, Seed points | 07/24/2023 |
| CPTAC-HNSCC-Tumor-Annotations | | | | | | 09/13/2023 |
| CPTAC-PDA-Tumor-Annotations | Ductal Adenocarcinoma | Pancreas | 103 | CPTAC-PDA | Tumor segmentations, Seed points | 07/24/2023 |
| CPTAC-UCEC-Tumor-Annotations | Corpus Endometrial Carcinoma | Uterus | 72 | CPTAC-UCEC | Tumor segmentations, Seed points | 07/24/2023 |
| Crowds-Cure-2017 | Lung Adenocarcinoma, Renal Clear Cell, Liver, Ovarian | Chest, Kidney, Liver, Ovary | 352 | TCGA-LUAD, TCGA-KIRC, TCGA-LIHC, TCGA-OV | Lesion measurements | 05/17/2018 |
| Crowds-Cure-2018 | Bladder Endothelial Carcinoma, Colon adenocarcinoma, Glioblastoma Multiforme, Head And Neck Squamous Cell Carcinoma, Lung Squamous Cell Carcinoma, Melanoma, Non-small Cell Lung Cancer, Pancreatic Ductal Adenocarcinoma, Renal Clear Cell Carcinoma, Uterine Corpus Endometrial Carcinoma | Bladder, Brain, Colon, Head-Neck, Kidney, Lung, Pancreas, Skin, Uterine corpus | 324 | ANTI-PD-1_LUNG, ANTI-PD-1_MELANOMA, CPTAC-CCRCC, CPTAC-GBM, CPTAC-HNSCC, CPTAC-PDA, CPTAC-UCEC, NSCLC-RADIOGENOMICS, TCGA-BLCA, TCGA-COAD, TCGA-HNSC, TCGA-LUSC, TCGA-UCEC | Lesion measurements | 05/30/2019 |
| DI-Cubed-Reports | Breast, Glioblastoma | Breast, Brain | 516 | ISPY1, BREAST-DIAGNOSIS, BREAST-MRI-NACT-PILOT, TCGA-BRCA, IVYGAP | Standardized (SDTM format) conversions of clinical and image analysis data | 06/21/2019 |
| DICOM-Glioma-SEG | | | | | | 09/13/2023 |
| DICOM-LIDC-IDRI-Nodules | Lung | Chest | 1,010 | LIDC-IDRI | Tumor segmentations, image features | 03/26/2020 |
| DICOM-SR-Breast-Clinical | Breast | Breast | 474 | TCGA-BRCA, BREAST-DIAGNOSIS, ISPY1, BREAST-MRI-NACT-PILOT | DICOM SR descriptions of patient characteristics, histopathology, receptor status and clinical findings including measurements. | 05/28/2020 |
| GBM-MR-NER-Outcomes | Glioblastoma | Brain | 45 | TCGA-GBM | | 07/24/2014 |
| Glioblastoma-Genomic-Mapping | | | | | | 09/13/2023 |
| Head-Neck-CT-Atlas | Head And Neck Squamous Cell Carcinoma | Head-Neck | 215 | CPTAC-HNSCC | Radiation Therapy Structures | 07/11/2019 |
| Image-Compression-Simulation | | | | | | 09/13/2023 |
| ISBI-MR-Prostate-2013 | Prostate | Prostate | 80 | PROSTATE-DIAGNOSIS, PROSTATE-3T | Prostate structure segmentations | 08/20/2015 |
| ISPY1-Tumor-SEG-Radiomics | Breast | Breast | 163 | ISPY1 | Tumor segmentations, radiomic features | 01/06/2022 |
| IvyGAP-Radiomics | Glioblastoma | Brain | 37 | IVYGAP | Tumor segmentations, radiomic features | 10/30/2020 |
| LUAD-CT-Survival | Lung Adenocarcinoma | Chest | 40 | LUNGCT-DIAGNOSIS, QIN-LUNG-CT | Tumor segmentations, radiomic image features | 08/11/2017 |
| LuminalB-Breast-MR-Enhancement | | | | | | 09/13/2023 |
| MRQy-Quality-Measures | Glioblastoma, Cervical Squamous Cell Carcinoma, Endocervical Adenocarcinoma | Brain, Cervix | 233 | TCGA-GBM, CPTAC-GBM, TCGA-CESC | Image quality assessment measures | 07/22/2020 |
| NSCLC Radiogenomics-Stanford | | | | | | 09/13/2023 |
| Pan-Cancer-Nuclei-Seg | Bladder Urothelial Carcinoma, Breast Invasive Carcinoma, Cervical Squamous Cell Carcinoma, Endocervical Adenocarcinoma, Glioblastoma Multiforme, Lung Adenocarcinoma, Lung Squamous Cell Carcinoma, Pancreatic adenocarcinoma, Prostate Adenocarcinoma, Skin Cutaneous Melanoma, Uterine Corpus Endometrial Carcinoma, Colon adenocarcinoma, Rectal Adenocarcinoma, Stomach Adenocarcinoma, Uveal Melanoma | Bladder, Brain, Breast, Colon, Eye, Lung, Pancreas, Prostate, Rectum, Stomach, Uterus, Endometrium | | TCGA-BLCA, TCGA-BRCA, TCGA-CESC, TCGA-COAD, TCGA-GBM, TCGA-LUAD, TCGA-LUSC, TCGA-PRAD, TCGA-READ, TCGA-STAD, TCGA-UCEC | Nuclei segmentations | 02/08/2020 |
| PleThora | | | | | | 09/13/2023 |
| PROSTATEx-Seg-HiRes | Prostate | Prostate | 66 | | Organ segmentations | 09/22/2020 |
| PROSTATEx-Seg-Zones | Prostate | Prostate | 98 | | Organ segmentations | 11/30/2020 |
| Pulmonary-Nodules-Segmentation | | | | | | 09/13/2023 |
| QIBA-VolCT-1B | Lung | Lung | 40 | RIDER-LUNG-PET-CT, RIDER-PILOT | Tumor segmentations, image features | 05/24/2023 |
| QIN-LungCT-Seg | Lung | Chest | 31 | LUNG-PHANTOM, LIDC-IDRI, QIN-LUNG-CT, RIDER-LUNG-PET-CT | Tumor segmentations | 12/18/2018 |
| Radiomic-Feature-Standards | Lung | Chest | 13 | LIDC-IDRI | Multi-center comparison of radiomic features. | 06/09/2020 |
| Radiomics outcome prediction in Oropharyngeal cancer | | | | | | 09/13/2023 |
| Radiomics-Tumor-Phenotypes | | | | | | 09/13/2023 |
| RIDER-LungCT-Seg | Lung | Chest | 31 | RIDER-LUNG-PET-CT | Tumor segmentations | 02/13/2020 |
| RSNA-ASNR-MICCAI-BraTS-2021 | Glioma | Brain | 1,480 | CPTAC-GBM, TCGA-GBM, TCGA-LGG, IVYGAP, UPENN-GBM, UCSF-PDGM | Tumor segmentations | 08/25/2023 |
| Spatial-Features-MRI-GBM | | | | | | 09/13/2023 |
| TCGA-Breast-Radiogenomics | Breast | Breast | 84 | TCGA-BRCA | Radiologist assessments of image features, Tumor segmentations, radiomic features, multi-gene assays | 09/04/2018 |
| TCGA-GBM-QI-Radiogenomics | Glioblastoma | Brain | 55 | TCGA-GBM | Tumor segmentations | 11/05/2014 |
| TCGA-GBM-Radiogenomics | Glioblastoma | Brain | 75 | TCGA-GBM | Radiologist assessments of image features | 11/12/2014 |
| TCGA-KIRC-Radiogenomics | Renal Clear Cell Carcinoma | Kidney | 103 | TCGA-KIRC | Radiologist assessments of image features | 05/28/2015 |
| TCGA-LGG-Mask | Low Grade Glioma | Brain | 188 | TCGA-LGG | Radiologist assessments of image features, Tumor segmentations | 03/17/2017 |
| TCGA-OV-Proteogenomics | Ovarian | Ovary | 20 | TCGA-OV | Radiologist assessments of image features, proteogenomic features | 04/15/2020 |
| TCGA-OV-Radiogenomics | High grade serous ovarian cancer | Ovary | 93 | TCGA-OV | Radiologist assessments of image features, genomic subtypes | 08/02/2016 |
| TIL-WSI-TCGA | Bladder Urothelial Carcinoma, Breast Invasive Carcinoma, Cervical Squamous Cell Carcinoma, Endocervical Adenocarcinoma, Colon adenocarcinoma, Lung Adenocarcinoma, Lung Squamous Cell Carcinoma, Pancreatic adenocarcinoma, Prostate Adenocarcinoma, Rectum Adenocarcinoma, Skin Cutaneous Melanoma, Stomach Adenocarcinoma, Uterine Corpus Endometrial Carcinoma, Uveal Melanoma | Bladder, Breast, Pelvic Cervix, Chest, Colon, Eye, Lung, Pancreas, Prostate, Rectum, Skin, Stomach, Uterus | 4,759 | TCGA-BLCA, TCGA-BRCA, TCGA-CESC, TCGA-COAD, TCGA-LUAD, TCGA-LUSC, TCGA-PRAD, TCGA-READ, TCGA-STAD, TCGA-UCEC | Deep learning based computational stain for staining tumor-infiltrating lymphocytes (TILs) | 12/17/2018 |